Jupiter Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

Jupiter Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$432K	Buy	+18,558	New	+$269K	0.01%	332
2019 Q3	–	Sell	-51	Closed	–	–	507
2019 Q2	$0	Sell	51 -28,848	-100%	-$348K	﹤0.01%	444
2019 Q1	$508K	Buy	28,899 +8,896	+44%	+$148K	﹤0.01%	296
2018 Q4	$347K	Buy	+20,003	New	+$341K	﹤0.01%	307
2016 Q3	–	Sell	-1,765	Closed	-$34K	–	474
2016 Q2	$34K	Sell	1,765 -17,933	-91%	-$352K	﹤0.01%	403
2016 Q1	$405K	Buy	+19,698	New	+$388K	0.01%	378

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Jupiter Investment Management's VIVO Position: Q2 2020 in Review

Jupiter Investment Management opened a new position in Meridian Bioscience Inc (VIVO) in Q2 2020: 18,558 shares worth $432K. The stake represents 0.01% of the portfolio and ranks #332 among its holdings. This is a return to the name: Jupiter Investment Management previously reported a position in VIVO as recently as Q2 2019.

Jupiter Investment Management first reported a position in VIVO in Q1 2016 and has held it in 6 quarters since. The position peaked at $508K in Q1 2019. 191 funds tracked by Wall St. Rank hold VIVO as of Q2 2020.

Jupiter Investment Management held 18,558 shares of Meridian Bioscience Inc worth $432K as of Q2 2020.
Meridian Bioscience Inc was a new Jupiter Investment Management position in Q2 2020.
Meridian Bioscience Inc made up 0.01% of Jupiter Investment Management's portfolio in Q2 2020, its #332 holding.
Jupiter Investment Management first reported a position in Meridian Bioscience Inc in Q1 2016 and has held it in 6 quarters since.
Jupiter Investment Management's Meridian Bioscience Inc position peaked at $508K in Q1 2019.
191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.